Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System

We estimated the costs of a molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) and of smear microscopy, within the Brazilian Sistema Único de Saúde (SUS, Unified Health Care System). In SUS laboratories in the cities of Rio de Janeiro and Manaus, we performed ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Márcia, Entringer, Aline Piovezan, Steffen, Ricardo, Trajman, Anete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722795/
https://www.ncbi.nlm.nih.gov/pubmed/26785963
http://dx.doi.org/10.1590/S1806-37562015000004524
_version_ 1782411420002942976
author Pinto, Márcia
Entringer, Aline Piovezan
Steffen, Ricardo
Trajman, Anete
author_facet Pinto, Márcia
Entringer, Aline Piovezan
Steffen, Ricardo
Trajman, Anete
author_sort Pinto, Márcia
collection PubMed
description We estimated the costs of a molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) and of smear microscopy, within the Brazilian Sistema Único de Saúde (SUS, Unified Health Care System). In SUS laboratories in the cities of Rio de Janeiro and Manaus, we performed activity-based costing and micro-costing. The mean unit costs for Xpert MTB/RIF and smear microscopy were R$35.57 and R$14.16, respectively. The major cost drivers for Xpert MTB/RIF and smear microscopy were consumables/reagents and staff, respectively. These results might facilitate future cost-effectiveness studies and inform the decision-making process regarding the expansion of Xpert MTB/RIF use in Brazil.
format Online
Article
Text
id pubmed-4722795
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-47227952016-01-27 Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System Pinto, Márcia Entringer, Aline Piovezan Steffen, Ricardo Trajman, Anete J Bras Pneumol Brief Communication We estimated the costs of a molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) and of smear microscopy, within the Brazilian Sistema Único de Saúde (SUS, Unified Health Care System). In SUS laboratories in the cities of Rio de Janeiro and Manaus, we performed activity-based costing and micro-costing. The mean unit costs for Xpert MTB/RIF and smear microscopy were R$35.57 and R$14.16, respectively. The major cost drivers for Xpert MTB/RIF and smear microscopy were consumables/reagents and staff, respectively. These results might facilitate future cost-effectiveness studies and inform the decision-making process regarding the expansion of Xpert MTB/RIF use in Brazil. Sociedade Brasileira de Pneumologia e Tisiologia 2015 /pmc/articles/PMC4722795/ /pubmed/26785963 http://dx.doi.org/10.1590/S1806-37562015000004524 Text en http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Brief Communication
Pinto, Márcia
Entringer, Aline Piovezan
Steffen, Ricardo
Trajman, Anete
Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
title Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
title_full Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
title_fullStr Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
title_full_unstemmed Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
title_short Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
title_sort cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the brazilian unified health care system
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722795/
https://www.ncbi.nlm.nih.gov/pubmed/26785963
http://dx.doi.org/10.1590/S1806-37562015000004524
work_keys_str_mv AT pintomarcia costanalysisofnucleicacidamplificationfordiagnosingpulmonarytuberculosiswithinthecontextofthebrazilianunifiedhealthcaresystem
AT entringeralinepiovezan costanalysisofnucleicacidamplificationfordiagnosingpulmonarytuberculosiswithinthecontextofthebrazilianunifiedhealthcaresystem
AT steffenricardo costanalysisofnucleicacidamplificationfordiagnosingpulmonarytuberculosiswithinthecontextofthebrazilianunifiedhealthcaresystem
AT trajmananete costanalysisofnucleicacidamplificationfordiagnosingpulmonarytuberculosiswithinthecontextofthebrazilianunifiedhealthcaresystem

Ejemplares similares